Allogene Therapeutics Inc (ALLO)
3.07
+0.10
(+3.37%)
USD |
NASDAQ |
May 03, 16:00
3.065
0.00 (0.00%)
After-Hours: 20:00
Allogene Therapeutics PE Value
PE Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical PE Value Data
Date | Value |
---|
PE Value (Pro) Definition
This valuation method corrects for any recent price appreciations for discounts by assuming that the value of the company will be in line with its historical valuations based on PE ratios. It will show companies that have recently increased in price, without an accompanying increase in earnings, to be overvalued, and it will show companies with a recent decrease in price, without an accompanying decrease in earnings, to be undervalued.
PE Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
PE Value Benchmarks
Agenus Inc | -- |
ANI Pharmaceuticals Inc | -- |
Vaxart Inc | -- |
aTyr Pharma Inc | -- |
PAVmed Inc | -- |